gabapentin
Generic: gabapentin
Labeler: preferred pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
preferred pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-7757
Product ID
68788-7757_f2ea7af9-8f70-4e3c-9992-ab634d0259b5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205101
Listing Expiration
2026-12-31
Marketing Start
2020-07-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687887757
Hyphenated Format
68788-7757
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA205101 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (68788-7757-1)
- 30 TABLET in 1 BOTTLE (68788-7757-3)
- 60 TABLET in 1 BOTTLE (68788-7757-6)
- 120 TABLET in 1 BOTTLE (68788-7757-8)
- 90 TABLET in 1 BOTTLE (68788-7757-9)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f2ea7af9-8f70-4e3c-9992-ab634d0259b5", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310434"], "spl_set_id": ["561f53d5-5301-42b3-b372-f3d49d642a2e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-7757-1)", "package_ndc": "68788-7757-1", "marketing_start_date": "20200701"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-7757-3)", "package_ndc": "68788-7757-3", "marketing_start_date": "20200701"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-7757-6)", "package_ndc": "68788-7757-6", "marketing_start_date": "20200701"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (68788-7757-8)", "package_ndc": "68788-7757-8", "marketing_start_date": "20200701"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-7757-9)", "package_ndc": "68788-7757-9", "marketing_start_date": "20200701"}], "brand_name": "Gabapentin", "product_id": "68788-7757_f2ea7af9-8f70-4e3c-9992-ab634d0259b5", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-7757", "generic_name": "Gabapentin", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA205101", "marketing_category": "ANDA", "marketing_start_date": "20200701", "listing_expiration_date": "20261231"}